Akero Therapeutics Inc (AKRO)
20.80
+0.50
(+2.46%)
USD |
NASDAQ |
May 15, 15:24
Akero Therapeutics Stock Buybacks (Quarterly): -355.44M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -355.44M |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | -335.43M |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | -216.20M |
June 30, 2022 | -25.00M |
March 31, 2022 | |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
Date | Value |
---|---|
March 31, 2021 | |
December 31, 2020 | 0.00 |
September 30, 2020 | -202.55M |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | 0.00 |
September 30, 2019 | 1.628M |
June 30, 2019 | -97.08M |
March 31, 2019 | |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-355.44M
Minimum
Mar 2024
1.628M
Maximum
Sep 2019
-76.88M
Average
--
Median
Dec 2019
Stock Buybacks (Quarterly) Benchmarks
89bio Inc | -21.07M |
Madrigal Pharmaceuticals Inc | -311.56M |
Viking Therapeutics Inc | -597.12M |
Ionis Pharmaceuticals Inc | -23.61M |
Galectin Therapeutics Inc | -- |